CALSADA CRISPINA
Insider CIK 1606833 · RGLS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 5,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 48,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 15,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 21,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 10,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 562,500 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 462,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 85,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 375,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer deriv | 2025-06-25 | 2025-06-27 | 45,000 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | D To issuer | 2025-06-25 | 2025-06-27 | 140,228 | — | $0 | 0 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2025-01-30 | 2025-01-31 | 562,500 | — | $0 | 562,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2025-01-14 | 2025-01-15 | 5,088 | $1.26 | $6.4K | 45,478 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2025-01-13 | 2025-01-15 | 38,716 | $1.26 | $48.8K | 50,566 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2025-01-09 | 2025-01-10 | 21,000 | $1.30 | $27.3K | 89,282 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2025-01-09 | 2025-01-10 | 62,500 | $1.36 | $85.0K | 68,282 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-05-20 | 2024-05-21 | 462,000 | — | $0 | 462,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2024-01-18 | 2024-01-18 | 5,468 | $1.19 | $6.5K | 5,782 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2024-01-12 | 2024-01-17 | 85,000 | — | $0 | 85,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2024-01-12 | 2024-01-17 | 11,250 | — | $0 | 11,250 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-08-10 | 2023-08-14 | 375,000 | — | $0 | 375,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2023-01-11 | 2023-01-17 | 45,000 | — | $0 | 45,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2022-05-10 | 2022-05-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2022-01-12 | 2022-01-26 | 480,000 | — | $0 | 480,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2021-02-04 | 2021-02-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2020-01-22 | 2020-01-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-10-10 | 2019-10-15 | 210,000 | — | $0 | 210,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-08-30 | 2019-09-03 | 100,000 | — | $0 | 100,000 | SEC↗ |